🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10,225 results for “He” Clear

  1. aspirin and clopidogrel

    The First People's Hospital of Lianyungang

    Atrial Fibrillation

    approved small molecule active

    1 trial

  2. berberine hydrochloride

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  3. buprenorphine

    Indivior Pty Ltd

    Hepatitis C, Chronic

    approved small molecule terminated

    1 trial

  4. buprenorphine/naloxone

    BICYCLE THERAPEUTICS

    Opioid Use Disorder

    approved small molecule terminated

    1 trial

  5. butylphthalide(NBP)

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    approved small molecule completed

    1 trial

  6. combined fixed dose combination

    United Therapeutics Europe Ltd

    Tuberculosis

    approved small molecule active

    1 trial

  7. combined fixed dose combination

    Gain Therapeutics

    Tuberculosis

    approved small molecule active

    1 trial

  8. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    approved other active

    1 trial

  9. dapagliflozin

    The First People's Hospital of Lianyungang

    Diabetic Kidney Disease

    approved small molecule active

    1 trial

  10. dexmedetomidine

    The First People's Hospital of Lianyungang

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  11. dexmedetomidine

    The First People's Hospital of Lianyungang

    Aged

    approved small molecule completed

    3 trials

  12. dexmedetomidine hydrochloride for injection

    The First People's Hospital of Lianyungang

    Delirium

    approved small molecule completed

    1 trial

  13. dipyridamole

    United Therapeutics Europe Ltd

    Coronary Artery Disease

    approved small molecule terminated

    1 trial

  14. docetaxel

    Hoffmann-La Roche

    Breast Cancer

    approved small molecule completed

    2 trials

  15. early standardised rhythm control

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial

  16. entecavir

    The First People's Hospital of Lianyungang

    Liver Fibrosis

    approved small molecule completed

    1 trial

  17. epoetin beta [NeoRecormon]

    Hoffmann-La Roche

    Anemia

    approved small molecule terminated

    1 trial

  18. film dressing by adhesive

    Chinese University of Hong Kong

    Chronic Peritoneal Dialysis

    approved other terminated

    1 trial

  19. first-line scheme+compound kushen injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Colorectal Carcinoma

    approved small molecule active

    1 trial

  20. fluocinolone acetonide 190 micrograms

    ANI PHARMACEUTICALS INC

    Non-infectious Uveitis Affecting the Posterior Segment of the Eye

    approved small molecule active

    1 trial

  21. ginkgolide

    The First People's Hospital of Lianyungang

    Intravenous Alteplase Thrombolysis

    approved small molecule completed

    1 trial

  22. half-dose ticagrelor

    The First People's Hospital of Lianyungang

    Acute Coronary Syndrome

    approved small molecule active

    1 trial

  23. hepatitis B vaccine made by Recombinant DNA Techniques in Saccharomyces Cerevisiae

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B Vaccines

    approved mab completed

    1 trial

  24. hyaluronidase (human recombinant)/rehydration fluid

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources